It is a pharma private limited company based in Delhi, Delhi, India, established in 2015.
2015 | Delhi, Delhi, India | ActiveKindcare Drugs Private Limited, a active private limited company, was established on 13 April 2015 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51101DL2015PTC279004. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Kavi Agarwal (Director), Ruchi Agarwal (Director), Vineet Agarwal (Director). Past directors included Kavi Agarwal, Yashaswini Bindal, Anuradha Agarwal. It holds ₹3.60 Cr open charges and ₹5.60 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S-551-A School Block Shakarpur, Delhi, Delhi, 110092.
U51101DL2015PTC279004
279004
13 April 2015
₹1.00 M
₹0.20 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Kindcare Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kavi Agarwal | Director | 05 Jan 2017 | Current |
| Ruchi Agarwal | Director | 01 Mar 2021 | Current |
| Vineet Agarwal | Director | 13 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 May 2022 | Past |
| Pramod Abcsdd | Director | 01 Sep 2017 | Past |
| Pramod Abcsdd | Director | 01 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kindcare Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.35% increase. The company also saw a substantial improvement in profitability, with a 22.51% increase in profit. The company's net worth Soared by an impressive increase of 37.47%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Kindcare Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹36,000,000.00
₹5,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Mar 2025 | Others | ₹2.60 Cr | Open |
| 25 Jun 2024 | Others | ₹1.00 Cr | Open |
| 12 Jul 2023 | Others | ₹5.60 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kindcare Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kindcare Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kindcare Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 26.00 M with Charge ID 101083494 was registered on 18 Mar 2025. was documented.
The activity Kindcare Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge registered on 12 Jul 2023 via Charge ID 100798291 with Others was fully satisfied on 09 Jul 2024. was completed.
The activity A charge with Others amounted to Rs. 10.00 M with Charge ID 100951653 was registered on 25 Jun 2024. was completed.
Progress on Kindcare Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on A charge with Others amounted to Rs. 5.60 M with Charge ID 100798291 was registered on 12 Jul 2023. was documented.
The CIN of Kindcare Drugs Private Limited is U51101DL2015PTC279004.
Kindcare Drugs Private Limited is headquartered at S-551-A School Block Shakarpur, Delhi, Delhi, 110092.
Kindcare Drugs Private Limited was incorporated on 13 April 2015.
The current directors of Kindcare Drugs Private Limited are
The primary industry of Kindcare Drugs Private Limited is Trade.
Kindcare Drugs Private Limited is unlisted.
The authorized capital of Kindcare Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.
The compliance status of Kindcare Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX